[Prevalence of patients with HIV receiving outpatient medical care in Germany-an analysis based on secondary data].

Häufigkeiten von Patienten mit HIV in der ambulanten Versorgung in Deutschland – Eine Analyse auf Basis von Sekundärdaten.
Administrative prevalence First diagnosis HIV Outcome research Secondary data

Journal

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
ISSN: 1437-1588
Titre abrégé: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Pays: Germany
ID NLM: 101181368

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 29 11 2019
accepted: 21 08 2020
pubmed: 25 9 2020
medline: 3 10 2020
entrez: 24 9 2020
Statut: ppublish

Résumé

The Robert Koch Institute (RKI) annually publishes an estimate of the number of new HIV diagnoses and the total number of people diagnosed with HIV in Germany. So far, only medication prescription data have served as secondary data as a basis for such estimates. In this study, we used billing data from the outpatient sector to estimate the number of patients with newly diagnosed HIV, the overall number of patients with HIV, and the HIV test rates in those with statutory health insurance in Germany. We analyzed billing data from the outpatient sector for all persons covered by statutory health insurance between 2009 and 2018. We designed annual cohorts of patient for the years 2011 to 2017 and analyzed the number of HIV diagnoses, the number of HIV-related care services, and HIV testing rates. Every year, about 6000 new patients with HIV are treated in outpatient care. The total number of patients with HIV in 2011 was about 59,300 (0.106%), which increased to 80,800 (0.141%) in 2017. The average increase in the total number of patients per year of about 3600 was significantly below the estimated number of newly treated patients for each year. The results may provide an indication of patients receiving HIV care in the outpatient sector. The secondary data provide the possibility of developing another epidemiological data source for population-based representation of the administrative prevalence of HIV. To clarify over-representation, there is a need for further research on patients who are using outpatient care for the first time.

Sections du résumé

BACKGROUND BACKGROUND
The Robert Koch Institute (RKI) annually publishes an estimate of the number of new HIV diagnoses and the total number of people diagnosed with HIV in Germany. So far, only medication prescription data have served as secondary data as a basis for such estimates.
OBJECTIVES OBJECTIVE
In this study, we used billing data from the outpatient sector to estimate the number of patients with newly diagnosed HIV, the overall number of patients with HIV, and the HIV test rates in those with statutory health insurance in Germany.
MATERIALS AND METHODS METHODS
We analyzed billing data from the outpatient sector for all persons covered by statutory health insurance between 2009 and 2018. We designed annual cohorts of patient for the years 2011 to 2017 and analyzed the number of HIV diagnoses, the number of HIV-related care services, and HIV testing rates.
RESULTS RESULTS
Every year, about 6000 new patients with HIV are treated in outpatient care. The total number of patients with HIV in 2011 was about 59,300 (0.106%), which increased to 80,800 (0.141%) in 2017. The average increase in the total number of patients per year of about 3600 was significantly below the estimated number of newly treated patients for each year.
CONCLUSION CONCLUSIONS
The results may provide an indication of patients receiving HIV care in the outpatient sector. The secondary data provide the possibility of developing another epidemiological data source for population-based representation of the administrative prevalence of HIV. To clarify over-representation, there is a need for further research on patients who are using outpatient care for the first time.

Identifiants

pubmed: 32970170
doi: 10.1007/s00103-020-03216-6
pii: 10.1007/s00103-020-03216-6
doi:

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

1250-1261

Auteurs

Diana Kurch-Bek (D)

Innovation, strategische Analyse und IT-Beratung, Kassenärztliche Bundesvereinigung, Herbert-Lewin-Platz 2, 10623, Berlin, Deutschland. dkurch-bek@kbv.de.

Christian Gallowitz (C)

Innovation, strategische Analyse und IT-Beratung, Kassenärztliche Bundesvereinigung, Herbert-Lewin-Platz 2, 10623, Berlin, Deutschland.

Axel Baumgarten (A)

Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung HIV-Infizierter (dagnä) e. V., Berlin, Deutschland.

Bernhard Tenckhoff (B)

Innovation, strategische Analyse und IT-Beratung, Kassenärztliche Bundesvereinigung, Herbert-Lewin-Platz 2, 10623, Berlin, Deutschland.

Matthias An der Heiden (M)

Fachgebiet für HIV/AIDS und andere sexuell oder durch Blut übertragbare Infektionen, Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH